Saint-Petersburg, Russia

Natalia Eugenievna Pestova

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Joint Stock Company "Biocad". Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Natalia Eugenievna Pestova. Retrieved from https://idiyas.com/inventor/natalia-eugenievna-pestova

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 18.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Natalia Eugenievna Pestova: Innovator in Biotechnology

Introduction

Natalia Eugenievna Pestova is a prominent inventor based in St. Petersburg, Russia. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work has the potential to impact various therapeutic applications.

Latest Patents

Natalia holds a patent for a monoclonal antibody that specifically binds to CD20. This invention relates to biotechnology and provides a monoclonal antibody that can be utilized in various medical treatments. The patent also encompasses DNA encoding the antibody, corresponding expression vectors, and methods of production, as well as treatment methods using the antibody. She has 1 patent to her name.

Career Highlights

Natalia is currently employed at Biocad, a leading biotechnology company in Russia. Her role at Biocad allows her to engage in cutting-edge research and development, contributing to advancements in medical science.

Collaborations

Natalia has collaborated with notable colleagues, including Iana Andreevna Smirnova and Arina Vitalevna Anikina. These collaborations enhance her research efforts and foster innovation within her field.

Conclusion

Natalia Eugenievna Pestova is a key figure in biotechnology, with her innovative work on monoclonal antibodies paving the way for future medical advancements. Her contributions are vital to the ongoing development of effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…